GTXI

GTXI: Q2 Earnings Call @ 09:00 ET Today [delayed] - 08/05 - 07:28 AM ET

GTXI: Data Safety Monitoring Board Recommends Continuation of Ph III Trial - 07/28 - 08:25 AM ET

GTx Announces Phase III Clinical Development of Toremifene 20 mg on Course Following Planned Safety Review - 07/28 - 06:00 AM ET

GTx, Inc. Announces Second Quarter 2008 Financial Results Conference Call and Webcast - 07/22 - 07:00 AM ET

GTx Inc. (GTXI) Corporate Event Announcement Notice - 07/02 - 08:58 PM ET

GTx Inc. (GTXI) Corporate Event Announcement Notice - 07/01 - 08:52 PM ET

GTXI: To Present At Goldman Sachs Healthcare Conference @ 16:20 ET [delayed] - 06/10 - 02:52 PM ET

GTx Shares Tumble On Continuation Of Prostate Cancer Drug Acapodene Trial - 05/27 - 10:26 AM ET

The Maybach Financial Group: GTx Announces Phase III PIN Clinical Trial Will Continue As Planned - 05/24 - 04:03 AM ET

Independent Group Recommends Continuation Of GTx's Toremifene Trial - 05/23 - 12:45 PM ET

Street Tips: GTx Announces Phase III PIN Clinical Trial Will Continue As Planned - 05/23 - 12:20 PM ET

GTX down; recommendation it continue late-stage trial of prostate cancer drug - 05/23 - 10:57 AM ET

GTX INC. DOWNGRADED TO NEUTRAL AT COWEN - 05/23 - 10:33 AM ET

GTX INC. PRICE TARGET CUT TO $15 FROM $20 AT CITIGROUP - 05/23 - 10:33 AM ET

GTX INC. 12-MONTH PRICE TARGET CUT TO $24 FROM $30 AT GOLDMAN SACHS - 05/23 - 10:27 AM ET

GTX Inc. Drops In Pre-Market To Hit 2-Month Low - 05/23 - 08:47 AM ET

GTx Announces Phase III PIN Clinical Trial Will Continue As Planned - 05/23 - 06:00 AM ET

GTx Inc. (GTXI) Corporate Event Announcement Notice - 05/13 - 09:02 PM ET

GTXI: To Present At Bank of America Healthcare Conference @ 20:20 ET [delayed] - 05/13 - 06:53 PM ET

MG Strategies: GTx, Inc. Reports First Quarter 2008 Financial Results - 05/13 - 03:51 AM ET

Page 1 of 5     1  2   3   4   5      Previous  |  Next

<< Back to Stock Index